Form 4 Tracker
Peter A. Thompson

Director; Director, 10% Owner · 5 filings · Latest: May 7, 2026

Corvus Pharmaceuticals, Inc.
Sionna Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
SION
Peter A. ThompsonDirectorMay 11, 2026
Sale
$46.22184,639$8.5M2,671,822
SION
Peter A. ThompsonDirectorMay 8, 2026
Sale
$44.5859,767$2.7M2,856,461
SION
Peter A. ThompsonDirectorMay 7, 2026
Sale
$44.6148,546$2.2M2,916,228
SION
Peter A. ThompsonDirectorApr 18, 2026
Sale
$44.522,948$131.2K2,964,774
SION
Peter A. ThompsonDirectorApr 17, 2026
Sale
$44.6852,397$2.3M2,967,722
SION
Peter A. ThompsonDirectorApr 16, 2026
Sale
$45.34226,906$10.3M3,020,119
SION
Peter A. ThompsonDirectorApr 15, 2026
Sale
$44.64235,863$10.5M3,247,025
SION
Peter A. ThompsonDirectorApr 14, 2026
Sale
$44.5147,814$2.1M3,482,888
SION
Peter A. ThompsonDirectorFeb 3, 2026
Sale
$44.5829,063$1.3M3,530,702
SION
Peter A. ThompsonDirectorFeb 2, 2026
Sale
$44.571,890$84.2K3,559,765
CRVS
Peter A. ThompsonDirector, 10% OwnerJan 28, 2026
Option Exercise
$5.33210,000$1.1M210,000